Glassboro, NJ, United States of America

Mary Elizabeth Locke

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: E.i. Dupont De Nemours and Company. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary Elizabeth Locke. Retrieved from https://idiyas.com/inventor/mary-elizabeth-locke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mary Elizabeth Locke: Innovator in Nucleic Acid Technology

Introduction

Mary Elizabeth Locke is a prominent inventor based in Glassboro, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid technology. Her work has implications for various applications in genetics and molecular biology.

Latest Patents

Mary Elizabeth Locke holds a patent for "Nucleic acid fragments, chimeric genes and methods for increasing the." This patent showcases her innovative approach to genetic engineering and the development of new methodologies in the field.

Career Highlights

Locke is currently employed at E.I. du Pont de Nemours and Company, a leading science and technology company. Her role at DuPont allows her to leverage her expertise in biotechnology and contribute to groundbreaking research and development projects.

Collaborations

Throughout her career, Mary has collaborated with notable colleagues, including Saverio Carl Falco and Anthony D. Guida, Jr. These partnerships have fostered a collaborative environment that enhances innovation and drives scientific discovery.

Conclusion

Mary Elizabeth Locke is a trailblazer in the field of nucleic acid technology, with a patent that reflects her innovative spirit. Her work at E.I. du Pont de Nemours and Company, along with her collaborations, underscores her commitment to advancing biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…